Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Total Voting Rights

1 Mar 2021 09:48

RNS Number : 6792Q
B&M European Value Retail S.A.
01 March 2021
 

 

 

 

01 March 2021

 

B&M European Value Retail S.A.

Total Voting Rights

 

In accordance with the Disclosure and Transparency Rules, B&M European Value Retail S.A. (the "Company") confirms that as at 28 February 2021 the issued share capital and voting rights of the Company are as follows.

 

The Company's issued share capital consists of 1,000,819,688 ordinary shares of 10 pence each with voting rights of one vote per share. There are no shares held by the Company in treasury.

 

Shareholders may use the above 1,000,819,688 total voting rights number as the denominator for the calculation by which they will determine if they are required to notify their interest or a change to their interest in the Company under the Disclosure and Transparency Rules.

 

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive

Alex Russo, Chief Financial Officer

investor.relations@bandmretail.com

 

 

 

 

 

 

 

ANNEX B

Form for the publication of the total number of voting rights and total share capital, in accordance with the law and Grand-Ducal regulation of 11 January 2008 relating to the disclosure requirements of issuers whose securities are admitted to trading

 

B&M European Value Retail S.A. - E1121

1. Identity of the issuer or the underlying issuer of shares with voting rights i (including the number of the issuer as allocated by the CSSF):

 

 

2. Identity of the person who is making the disclosure (if the notification is made by a third on behalf of the issuer)

n/a

 

 

3. Total number of shares representing the share capital of the issuer

1,000,819,688

 

4. Total number of voting rights attached to the shares representing the share capital of the issuer, including suspended voting ii

1,000,819,688

 

5. Total number of voting rights excluding suspended voting rights (exercisable voting rights) (optional)

1,000,819,688

 

6. Origin of the change iii

 

Share capital increase

 

7. Date on which the change has been recorded  15 February 2021

 

 

8. Last disclosure (optional)

 

 

 

 

 

 

 

 

 

__________________________________________________________________

i Indicate the full name of the legal entity or provide another means of reliable and certain identification of the issuer or underlying issuer.

 

ii For more details in relation to the total voting rights, please refer to CSSF Circular 08/249 1b.

 

iii Eg increase or decrease of the share capital.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUASKRANUORRR
Date   Source Headline
16th Jul 20218:00 amRNSDirector/PDMR Shareholding
14th Jul 202111:22 amRNSDirector/PDMR Shareholding
13th Jul 20219:00 amRNSBlock listing Interim Review
8th Jul 20217:00 amRNSTrading Statement
21st Jun 20217:00 amRNSAnnual Financial Report
3rd Jun 20217:00 amRNSBoard Change
3rd Jun 20217:00 amRNSPreliminary Results
15th Mar 202110:16 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSTrading Update
1st Mar 20219:48 amRNSTotal Voting Rights
25th Feb 20219:20 amRNSDirector Declaration
22nd Feb 20215:06 pmRNSDirector/PDMR Securities
10th Feb 20212:16 pmRNSHolding(s) in Company
9th Feb 202110:05 amRNSHolding(s) in Company
27th Jan 20217:00 amRNSHolding(s) in Company
20th Jan 20213:17 pmRNSHolding(s) in Company
20th Jan 202111:02 amRNSHolding(s) in Company
15th Jan 20214:02 pmRNSHolding(s) in Company
14th Jan 202112:52 pmRNSDirector/PDMR Shareholding
13th Jan 20219:24 amRNSBlock listing Interim Review
12th Jan 202110:00 amRNSDirector Declaration
12th Jan 20217:00 amRNSResults of Placing
11th Jan 20215:22 pmRNSProposed Secondary Placing
7th Jan 20217:00 amRNSTrading Statement
29th Dec 20209:25 amRNSDirector/PDMR Securities
29th Dec 20209:18 amRNSDirector/PDMR Securities
4th Dec 20207:00 amRNSResult of EGM
3rd Dec 20204:20 pmRNSTrading Update
17th Nov 202012:39 pmRNSDirector/PDMR Shareholding
16th Nov 202011:12 amRNSDirector/PDMR Shareholding
13th Nov 202012:35 pmRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSHalf-year Report
28th Oct 20207:00 amRNSNotice of EGM
30th Sep 20209:36 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSTrading Update
21st Sep 20209:53 amRNSResult of AGM
1st Sep 20209:40 amRNSTotal Voting Rights
30th Jul 202011:20 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSTrading Statement
20th Jul 20209:00 amRNSPost Stabilisation Notice
14th Jul 20209:50 amRNSDirector/PDMR Shareholding
13th Jul 20209:09 amRNSBlock listing Interim Review
9th Jul 20202:28 pmRNSBoard Changes
7th Jul 20204:05 pmRNSHolding(s) in Company
7th Jul 20209:01 amRNSHolding(s) in Company
2nd Jul 20206:19 pmRNSPricing of Senior Secured Notes Offering
1st Jul 202011:07 amRNSPre Stabilisation Notice
1st Jul 20209:02 amRNSLaunch of Senior Secured Notes Offering
1st Jul 20207:00 amRNSTrading Statement
1st Jul 20207:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.